Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes
- PMID: 7573713
- DOI: 10.4269/ajtmh.1995.53.278
Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes
Abstract
The T lymphocytes play an important role in prevention and recovery from viral infections. To characterize T lymphocyte responses to Japanese encephalitis (JE) virus infections, we analyzed JE virus-specific T lymphocytes in peripheral blood mononuclear cells (PBMC) obtained from seven JE patients and 10 vaccinees who had received a formalin-inactivated, purified JE virus vaccine (Biken vaccine). These PBMC were examined for proliferative responses against live JE virus, a glutaraldehyde-fixed lysate of cells infected with JE virus, and extracellular particles (EPs; subviral membrane vesicles released from cells infected with recombinant vaccinia viruses encoding the JE virus premembrane and envelope proteins). Japanese encephalitis virus-specific T cell proliferation was demonstrated with PBMC from both patients and vaccinees after stimulation with infectious JE virus or the lysate of JE virus-infected cells. Proliferating PBMC included CD4+ T lymphocytes and CD8+ T lymphocytes in responses to either form of JE viral antigens. Responses to EPs were observed only with PBMC from some American vaccinees whose PBMC also responded to the virus and lysate. These results indicate that JE virus infection and immunization with an inactivated JE vaccine induce JE virus-specific CD4+ and CD8+ T memory lymphocytes that can be induced to proliferate by infectious JE virus and noninfectious JE antigens.
Similar articles
-
Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice.Vaccine. 1997 Feb;15(3):281-6. doi: 10.1016/s0264-410x(96)00180-6. Vaccine. 1997. PMID: 9139487
-
T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.Viral Immunol. 2000;13(2):179-86. doi: 10.1089/vim.2000.13.179. Viral Immunol. 2000. PMID: 10892998
-
Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.Virology. 1997 Jan 20;227(2):353-60. doi: 10.1006/viro.1996.8331. Virology. 1997. PMID: 9018134
-
Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.Vaccine. 2000 May 26;18 Suppl 2:33-5. doi: 10.1016/s0264-410x(00)00041-4. Vaccine. 2000. PMID: 10821971 Review.
-
Japanese encephalitis vaccines: current vaccines and future prospects.Curr Top Microbiol Immunol. 2002;267:105-38. doi: 10.1007/978-3-642-59403-8_6. Curr Top Microbiol Immunol. 2002. PMID: 12082985 Review.
Cited by
-
Pathogenesis of flavivirus encephalitis.Adv Virus Res. 2003;60:273-342. doi: 10.1016/s0065-3527(03)60008-4. Adv Virus Res. 2003. PMID: 14689697 Free PMC article. Review.
-
The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes.J Virol. 1999 Jul;73(7):5527-34. doi: 10.1128/JVI.73.7.5527-5534.1999. J Virol. 1999. PMID: 10364301 Free PMC article.
-
Protective mechanisms induced by a Japanese encephalitis virus DNA vaccine: requirement for antibody but not CD8(+) cytotoxic T-cell responses.J Virol. 2001 Dec;75(23):11457-63. doi: 10.1128/JVI.75.23.11457-11463.2001. J Virol. 2001. PMID: 11689627 Free PMC article.
-
Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Hum Vaccin Immunother. 2017 Jun 3;13(6):1-18. doi: 10.1080/21645515.2017.1285472. Epub 2017 Feb 22. Hum Vaccin Immunother. 2017. PMID: 28301270 Free PMC article. Review.
-
Human T cell responses to Japanese encephalitis virus in health and disease.J Exp Med. 2016 Jun 27;213(7):1331-52. doi: 10.1084/jem.20151517. Epub 2016 May 30. J Exp Med. 2016. PMID: 27242166 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials